34.26
Finanzdaten der Definium Therapeutics Inc-Aktie (DFTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
26.78%
75.08
|
59.22 | 47.58 | 45.67 | 40.90 |
| Interest Income/Expense |
0.96%
1.233
|
1.245 | 1.268 | 1.274 | 2.338 |
| Operating Income/Loss |
26.78%
-75.08
|
-59.22 | -47.58 | -45.67 | -40.90 |
|
|
106.21%
-158.99
|
-77.10 | -50.44 | -67.27 | -42.74 |
| Basic Average Shares |
1.74%
110.68
|
108.79 | - | 85.89 | 85.35 |
| Diluted Average Shares |
1.74%
110.68
|
108.79 | - | 85.89 | 85.35 |
| Basic Earnings Per Share |
102.82%
-1.44
|
-0.71 | - | -0.78 | -0.50 |
| Diluted Earnings Per Share |
102.82%
-1.44
|
-0.71 | - | -0.78 | -0.50 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):